B Cell Metabolism and Autophagy in Autoimmunity

Front Immunol. 2021 Jun 7:12:681105. doi: 10.3389/fimmu.2021.681105. eCollection 2021.

Abstract

B cells are central to the pathogenesis of multiple autoimmune diseases, through antigen presentation, cytokine secretion, and the production of autoantibodies. During development and differentiation, B cells undergo drastic changes in their physiology. It is emerging that these are accompanied by equally significant shifts in metabolic phenotype, which may themselves also drive and enforce the functional properties of the cell. The dysfunction of B cells during autoimmunity is characterised by the breaching of tolerogenic checkpoints, and there is developing evidence that the metabolic state of B cells may contribute to this. Determining the metabolic phenotype of B cells in autoimmunity is an area of active study, and is important because intervention by metabolism-altering therapeutic approaches may represent an attractive treatment target.

Keywords: B cell; B cell development and differentiation; SLE - systemic lupus erythematosus; autoimmunity; autophagy; metabolism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Autoimmune Diseases / diagnosis
  • Autoimmune Diseases / etiology
  • Autoimmune Diseases / metabolism
  • Autoimmune Diseases / therapy
  • Autoimmunity*
  • Autophagy*
  • B-Lymphocytes / cytology
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / metabolism*
  • Biomarkers
  • Disease Susceptibility
  • Energy Metabolism*
  • Humans
  • Lymphocyte Activation / immunology
  • Lymphopoiesis
  • Molecular Targeted Therapy

Substances

  • Biomarkers